发明名称 INHIBITION OF MAP4K4 THROUGH RNAI
摘要 RNAi constructs directed to MAP4K4 that demonstrate unexpectedly high gene silencing activities, and uses thereof are disclosed. The blunt-ended constructs have a double-stranded region of 19-49 nucleotides. The constructs have selective minimal modifications to confer an optimal balance of biological activity, toxicity, stability, and target gene specificity. For example, the strands may be modified (e.g., one or both ends of the sense strand is modified by 2′-O-methyl groups), such that the construct is not cleaved by Dicer or other RNAse III, the antisense strand may also be modified by a 2′-O-methyl group at the penultimate 5′-end nucleotide to greatly reduce off-target silencing.
申请公布号 US2016115484(A1) 申请公布日期 2016.04.28
申请号 US201514728764 申请日期 2015.06.02
申请人 RXi Pharmaceuticals Corporation 发明人 Woolf Tod M.;Kamens Joanne;Khvorova Anastasia;Salomon William
分类号 C12N15/113 主分类号 C12N15/113
代理机构 代理人
主权项 1. A double-stranded RNA (dsRNA) for inhibiting expression of a MAP4K4 gene, comprising an antisense strand sequence that has complementarity to a target sequence on an mRNA of the MAP4K4 gene and a sense strand sequence that comprises at least 12 contiguous nucleotides of SEQ ID NO: 1, 3, 5, 7, 11, 12, 13, 15, 17, 19, 21, 25, 27, 31, 33, 35, 37, 45, or 50.
地址 Marlborough MA US